Zobrazeno 1 - 10
of 18
pro vyhledávání: '"Frumovitz MM"'
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Yoder AK; Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX., Lakomy DS; Department of Radiation Oncology, Washington University School of Medicine, St. Louis, MO., Wu J; Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX; The University of Texas School of Public Health, Houston, TX., Andring LM; Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX., Corrigan KL; Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX., Fellman B; Department of Biostatistics, The University of Texas MD Anderson Cancer Center, Houston, TX., Jhingran A; Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX., Klopp AH; Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX., Colbert LE; Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX., Soliman PT; Department of Gynecologic Oncology and Reproductive Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX., Frumovitz MM; Department of Gynecologic Oncology and Reproductive Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX., Peterson SK; Department of Behavioral Science, The University of Texas MD Anderson Cancer Center, Houston, TX., Lin LL; Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX. Electronic address: LLLin@mdanderson.org.
Publikováno v:
Brachytherapy [Brachytherapy] 2024 Jan-Feb; Vol. 23 (1), pp. 1-9. Date of Electronic Publication: 2023 Oct 31.
Autor:
Wei AZ; Columbia University Irving Medical Center, New York, New York, USA., Chen LN; Columbia University Irving Medical Center, New York, New York, USA., Orloff M; Thomas Jefferson University Sidney Kimmel Cancer Center, Philadelphia, Pennsylvania, USA., Ariyan CE; Memorial Sloan Kettering Cancer Center, New York, New York, USA., Asgari M; Harvard Medical School, Boston, Massachusetts, USA., Barker CA; Memorial Sloan Kettering Cancer Center, New York, New York, USA., Buchbinder E; Dana-Farber Cancer Institute/Harvard Cancer Center, Boston, Massachusetts, USA., Chandra S; Northwestern University Feinberg School of Medicine, Chicago, Illinois, USA., Couts K; University of Colorado School of Medicine, Aurora, Colorado, USA., Frumovitz MM; The University of Texas MD Anderson Cancer Center, Houston, Texas, USA., Futreal A; The University of Texas MD Anderson Cancer Center, Houston, Texas, USA., Gershenwald JE; The University of Texas MD Anderson Cancer Center, Houston, Texas, USA., Hanna EY; The University of Texas MD Anderson Cancer Center, Houston, Texas, USA., Izar B; Columbia University Irving Medical Center, New York, New York, USA., LeBlanc AK; National Institute of Health, Bethesda, Maryland, USA., Leitao MM Jr; Memorial Sloan Kettering Cancer Center, New York, New York, USA.; Department of Obstetrics and Gynecology, Weill Cornell Medical College, New York, New York, USA., Lipson EJ; Johns Hopkins University School of Medicine, Baltimore, Maryland, USA., Liu D; Dana-Farber Cancer Institute/Harvard Cancer Center, Boston, Massachusetts, USA., McCarter M; University of Colorado School of Medicine, Aurora, Colorado, USA., McQuade JL; The University of Texas MD Anderson Cancer Center, Houston, Texas, USA., Najjar Y; University of Pittsburgh Medical Center Hillman Cancer Center, Pittsburgh, Pennsylvania, USA., Rapisuwon S; Georgetown University/MedStar Health, Washington, DC, USA., Selig S; Melanoma Research Foundation, CURE OM, Washington, DC, USA., Shoushtari AN; Memorial Sloan Kettering Cancer Center, New York, New York, USA., Yeh I; University of California, San Francisco, San Francisco, California, USA., Schwartz GK; Case Comprehensive Cancer Center, Cleveland, Ohio, USA., Guo J; Peking University Cancer Hospital & Institute, Beijing, China., Patel SP; The University of Texas MD Anderson Cancer Center, Houston, Texas, USA., Carvajal RD; Northwell Health Cancer Institute, New Hyde Park, New York, USA.
Publikováno v:
Pigment cell & melanoma research [Pigment Cell Melanoma Res] 2023 Nov; Vol. 36 (6), pp. 542-556. Date of Electronic Publication: 2023 Oct 07.
Autor:
Son J; Department of Gynecologic Oncology and Reproductive Medicine, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA., Lin HY; Department of Biostatistics, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA., Fu S; Department of Investigational Cancer Therapeutics, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA., Biter AB; Department of Investigational Cancer Therapeutics, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA., Dumbrava EE; Department of Investigational Cancer Therapeutics, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA., Karp DD; Department of Investigational Cancer Therapeutics, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA., Naing A; Department of Investigational Cancer Therapeutics, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA., Pant S; Department of Investigational Cancer Therapeutics, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA., Piha-Paul SA; Department of Investigational Cancer Therapeutics, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA., Rodon J; Department of Investigational Cancer Therapeutics, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA., Subbiah V; Department of Investigational Cancer Therapeutics, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA., Tsimberidou AM; Department of Investigational Cancer Therapeutics, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA., Yap TA; Department of Investigational Cancer Therapeutics, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA., Frumovitz MM; Department of Gynecologic Oncology and Reproductive Medicine, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA., Jazaeri AA; Department of Gynecologic Oncology and Reproductive Medicine, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA., Ramirez PT; Department of Gynecologic Oncology and Reproductive Medicine, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA., Westin SN; Department of Gynecologic Oncology and Reproductive Medicine, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA., Yuan Y; Department of Biostatistics, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA., Meric-Bernstam F; Department of Investigational Cancer Therapeutics, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA., Hong DS; Department of Investigational Cancer Therapeutics, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
Publikováno v:
Journal of immunotherapy and precision oncology [J Immunother Precis Oncol] 2023 Jan 06; Vol. 6 (1), pp. 10-18. Date of Electronic Publication: 2023 Jan 06 (Print Publication: 2023).
Autor:
Sapienza LG; Department of Radiation Oncology, Dan L Duncan Comprehensive Cancer Center, Baylor College of Medicine, Houston, TX, USA. Electronic address: lucas.sapienza@bcm.edu., Thomas JJ; Department of Radiation Oncology, Dan L Duncan Comprehensive Cancer Center, Baylor College of Medicine, Houston, TX, USA., Showalter TN; Department of Radiation Oncology, University of Virginia Cancer Center, University of Virginia, Charlottesville, VA, USA., Echeverria AE; Department of Radiation Oncology, Dan L Duncan Comprehensive Cancer Center, Baylor College of Medicine, Houston, TX, USA., Ludwig MS; Department of Radiation Oncology, Dan L Duncan Comprehensive Cancer Center, Baylor College of Medicine, Houston, TX, USA., Chen AC; Department of Radiation Oncology, Dan L Duncan Comprehensive Cancer Center, Baylor College of Medicine, Houston, TX, USA; Department of Radiation Oncology, Michael E. DeBakey Veterans Affairs Medical Center, Houston, TX, USA., Jo E; Biostatistics and Informatics Shared Resource (BISR) Core, Dan L Duncan Comprehensive Cancer Center, Baylor College of Medicine, Houston, TX, USA., Calsavara VF; Department of Biostatistics and Bioinformatics, Samuel Oschin Cancer Center, Cedars-Sinai, Los Angeles, CA, USA., Hilsenbeck SG; Biostatistics and Informatics Shared Resource (BISR) Core, Dan L Duncan Comprehensive Cancer Center, Baylor College of Medicine, Houston, TX, USA., Jhingran A; Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Frumovitz MM; Department of Gynecologic Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Baiocchi G; Department of Gynecologic Oncology, A.C. Camargo Cancer Center, São Paulo, SP, Brazil.
Publikováno v:
Gynecologic oncology [Gynecol Oncol] 2022 Jun; Vol. 165 (3), pp. 642-649. Date of Electronic Publication: 2022 Apr 08.
Autor:
Ho JC; Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, United States., Fang P; Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, United States., Cardenas CE; Department of Radiation Physics, The University of Texas MD Anderson Cancer Center, Houston, United States., Mohamed ASR; Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, United States., Fuller CD; Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, United States., Allen PK; Department of Biostatistics, The University of Texas MD Anderson Cancer Center, Houston, United States., Bhosale PR; Department of Diagnostic Radiology, The University of Texas MD Anderson Cancer Center, Houston, United States., Frumovitz MM; Department of Gynecologic Oncology, The University of Texas MD Anderson Cancer Center, Houston, United States., Jhingran A; Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, United States., Klopp AH; Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, United States. Electronic address: aklopp@mdanderson.org.
Publikováno v:
Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology [Radiother Oncol] 2019 Jun; Vol. 135, pp. 58-64. Date of Electronic Publication: 2019 Mar 11.
Autor:
Jazaeri A; Department of Gynecologic Oncology and Reproductive Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, United States of America. Electronic address: aajazaeri@mdanderson.org., Coleman RL; Department of Gynecologic Oncology and Reproductive Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, United States of America., Sood AK; Department of Gynecologic Oncology and Reproductive Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, United States of America., Frumovitz MM; Department of Gynecologic Oncology and Reproductive Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, United States of America., Soliman PT; Department of Gynecologic Oncology and Reproductive Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, United States of America., Shafer A; Department of Gynecologic Oncology and Reproductive Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, United States of America., Cutrera JJ; Department of Gynecologic Oncology and Reproductive Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, United States of America., Klinger M; Department of Gynecologic Oncology and Reproductive Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, United States of America., Sharafi SE; Department of Gynecologic Oncology and Reproductive Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, United States of America., Johnson CAL; Department of Gynecologic Oncology and Reproductive Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, United States of America., Villanueva VF; Department of Gynecologic Oncology and Reproductive Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, United States of America., Hinchcliff EM; Department of Gynecologic Oncology and Reproductive Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, United States of America., Dickens A; Division of Pharmacy, The University of Texas MD Anderson Cancer Center, Houston, TX, United States of America., Cain KE; Division of Pharmacy, The University of Texas MD Anderson Cancer Center, Houston, TX, United States of America., Anderson JE; Division of Pharmacy, The University of Texas MD Anderson Cancer Center, Houston, TX, United States of America; Department of Melanoma Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, United States of America., Lu KH; Department of Gynecologic Oncology and Reproductive Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, United States of America., Westin SN; Department of Gynecologic Oncology and Reproductive Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, United States of America.
Publikováno v:
Gynecologic oncology [Gynecol Oncol] 2018 Nov; Vol. 151 (2), pp. 374-380. Date of Electronic Publication: 2018 Sep 10.
Autor:
Ring KL; Division of Gynecologic Oncology, Department of Obstetrics and Gynecology, University of Virginia Health System, PO Box 800712, Charlottesville, VA, United States. Electronic address: kel7j@virginia.edu., Yemelyanova AV; Department of Pathology, The University of Texas MD Anderson Cancer Center, 1515 Holcombe Blvd, Houston, TX, United States. Electronic address: ayemeyanova@mdanderson.org., Soliman PT; Department of Gynecologic Oncology and Reproductive Medicine, The University of Texas MD Anderson Cancer Center, 1515 Holcombe Blvd, Unit 1362, Houston, TX, United States. Electronic address: psoliman@mdanderson.org., Frumovitz MM; Department of Gynecologic Oncology and Reproductive Medicine, The University of Texas MD Anderson Cancer Center, 1515 Holcombe Blvd, Unit 1362, Houston, TX, United States. Electronic address: mfrumovitz@mdanderson.org., Jazaeri AA; Department of Gynecologic Oncology and Reproductive Medicine, The University of Texas MD Anderson Cancer Center, 1515 Holcombe Blvd, Unit 1362, Houston, TX, United States. Electronic address: aajazaeri@mdanderson.org.
Publikováno v:
Gynecologic oncology [Gynecol Oncol] 2017 Jun; Vol. 145 (3), pp. 462-468. Date of Electronic Publication: 2017 Feb 21.
Autor:
Westin SN; Department of Gynecologic Oncology and Reproductive Medicine, University of Texas MD Anderson Cancer Center, 1155 Herman Pressler Boulevard, Unit 1362, CPB6.3279, Houston, TX, 77030, USA. swestin@mdanderson.org., Sun CC; Department of Gynecologic Oncology and Reproductive Medicine, University of Texas MD Anderson Cancer Center, 1155 Herman Pressler Boulevard, Unit 1362, CPB6.3279, Houston, TX, 77030, USA., Tung CS; Department of Obstetrics and Gynecology, Baylor College of Medicine, Houston, TX, USA., Lacour RA; Department of Obstetrics and Gynecology, Louisiana State University Health Sciences Center - Shreveport, Shreveport, LA, USA., Meyer LA; Department of Gynecologic Oncology and Reproductive Medicine, University of Texas MD Anderson Cancer Center, 1155 Herman Pressler Boulevard, Unit 1362, CPB6.3279, Houston, TX, 77030, USA., Urbauer DL; Division of Quantitative Sciences, University of Texas MD Anderson Cancer Center, Houston, TX, USA., Frumovitz MM; Department of Gynecologic Oncology and Reproductive Medicine, University of Texas MD Anderson Cancer Center, 1155 Herman Pressler Boulevard, Unit 1362, CPB6.3279, Houston, TX, 77030, USA., Lu KH; Department of Gynecologic Oncology and Reproductive Medicine, University of Texas MD Anderson Cancer Center, 1155 Herman Pressler Boulevard, Unit 1362, CPB6.3279, Houston, TX, 77030, USA., Bodurka DC; Department of Gynecologic Oncology and Reproductive Medicine, University of Texas MD Anderson Cancer Center, 1155 Herman Pressler Boulevard, Unit 1362, CPB6.3279, Houston, TX, 77030, USA.
Publikováno v:
Journal of cancer survivorship : research and practice [J Cancer Surviv] 2016 Apr; Vol. 10 (2), pp. 261-70. Date of Electronic Publication: 2015 Aug 06.